Summary
Updated Aug 31, 2026
Nancy Ryan Gray is Director of LIGAND PHARMACEUTICALS INC (LGND). 2 SEC Form 4 filings on record going back to 2025, most recently on 9 June 2026. Most recent open-market trade: sold $619K of LGND on 12 November 2025. Lifetime open-market sales: $1.35M.
Recent Transactions
5Every recent SEC Form 4 transaction Nancy Ryan Gray has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Nancy Ryan Gray go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Nancy Ryan Gray files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M of LGND open-market activity in the last 12 months
- Andrew Reardon - $7.34M of LGND open-market activity in the last 12 months
- Jason Haas - $3.74M of LGND open-market activity in the last 12 months
- Jason Aryeh - $2.96M of LGND open-market activity in the last 12 months
- John L. Lamattina - $2.44M of LGND open-market activity in the last 12 months
- John W. Kozarich - $1.18M of LGND open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Nancy Ryan Gray?
Nancy Ryan Gray is a corporate insider, tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nancy Ryan Gray submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Nancy Ryan Gray been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.35M) across all tracked filings.
Where can I see all of Nancy Ryan Gray's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Nancy Ryan Gray and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial